Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:79096OMIM:610090G40.8
Who is this for?
Show terms as
1Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pyridoxamine-5-phosphate oxidase deficiency (also called PNPO deficiency or PMP oxidase deficiency) is a very rare inherited brain disorder that affects how the body processes vitamin B6. The body needs a specific form of vitamin B6 called pyridoxal-5-phosphate (PLP) to keep the brain working properly. In this condition, a faulty gene means the body cannot make enough PLP, which causes the brain to become starved of a critical chemical it needs to function. This leads to a type of severe brain disorder called a developmental and epileptic encephalopathy. The most striking feature of this disease is seizures that begin very early in life, often within hours or days of birth. These seizures are usually very hard to control with standard anti-seizure medicines. Babies may also show signs of brain distress before birth, such as abnormal movements in the womb. Without early treatment, the ongoing seizures cause serious damage to the developing brain, leading to intellectual disability and developmental delays. The good news is that this condition can be treated with vitamin B6 supplements, specifically pyridoxal-5-phosphate (PLP) or sometimes pyridoxine. Starting treatment as early as possible is critical to protecting the brain and improving outcomes. Children who are diagnosed and treated quickly have a better chance of reaching developmental milestones, though many still face ongoing challenges.

Also known as:

Key symptoms:

Seizures starting in the first days of life that are very hard to controlAbnormal brain electrical activity seen on EEGIntellectual disability or significant learning difficultiesDelayed development (sitting, walking, talking later than expected)Low muscle tone (floppy baby)Irritability and poor feeding in newbornsAbnormal eye movementsEpisodes of stopped breathing (apnea) in newbornsAbnormal movements or jerking before or after birthSmall head size (microcephaly) in some childrenBrain abnormalities visible on MRI scan

Clinical phenotype terms (29)— hover any for plain English
Epileptic encephalopathyHP:0200134Abnormality of the amniotic fluidHP:0001560Global brain atrophyHP:0002283Decreased CSF homovanillic acid concentrationHP:0003785HypoargininemiaHP:0005961EEG with burst suppressionHP:0010851
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Feb 2024Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency

Medicure — PHASE3

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Phase 31 trial
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
Phase 3
Actively Recruiting
· Sites: Birmingham, Alabama; Palo Alto, California +5 more

No specialists are currently listed for Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathyForum →

No community posts yet. Be the first to share your experience with Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy.

Start the conversation →

Latest news about Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy

Disease timeline:

New recruiting trial: Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency

A new clinical trial is recruiting patients for Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the best form and dose of vitamin B6 for my child, and how will we know if it is working?,How quickly should we expect seizures to improve after starting PLP treatment, and what should we do if they do not?,Should we do genetic testing on other family members, and what are the chances of this happening in a future pregnancy?,What therapies (physical, speech, occupational) should my child start, and how soon?,Are there any signs of vitamin B6 toxicity I should watch for at home?,Does my child need an emergency seizure rescue plan, and what medicines should we have at home?,Is there a newborn screening test available so future siblings could be diagnosed earlier?

Common questions about Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy

What is Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy?

Pyridoxamine-5-phosphate oxidase deficiency (also called PNPO deficiency or PMP oxidase deficiency) is a very rare inherited brain disorder that affects how the body processes vitamin B6. The body needs a specific form of vitamin B6 called pyridoxal-5-phosphate (PLP) to keep the brain working properly. In this condition, a faulty gene means the body cannot make enough PLP, which causes the brain to become starved of a critical chemical it needs to function. This leads to a type of severe brain disorder called a developmental and epileptic encephalopathy. The most striking feature of this dise

How is Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy inherited?

Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy typically begin?

Typical onset of Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy?

Yes — 1 recruiting clinical trial is currently listed for Pyridoxamine-5-phosphate deficiency-developmental and epileptic encephalopathy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.